Pictet Asset Management Holding SA Sells 31,044 Shares of Revvity, Inc. (NYSE:RVTY)

Pictet Asset Management Holding SA reduced its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 2.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,121,454 shares of the company's stock after selling 31,044 shares during the period. Pictet Asset Management Holding SA owned 0.92% of Revvity worth $125,165,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Assetmark Inc. grew its stake in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock worth $30,000 after buying an additional 259 shares in the last quarter. Continuum Advisory LLC raised its position in shares of Revvity by 2,972.7% during the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after buying an additional 327 shares in the last quarter. Millstone Evans Group LLC bought a new position in shares of Revvity in the 4th quarter valued at about $38,000. MassMutual Private Wealth & Trust FSB grew its position in Revvity by 55.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after acquiring an additional 138 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after acquiring an additional 131 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider Joel S. Goldberg sold 15,170 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company's stock, valued at $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Tajinder S. Vohra sold 5,492 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.68% of the stock is owned by insiders.

Remove Ads

Revvity Trading Up 2.1 %

RVTY stock traded up $2.15 during mid-day trading on Wednesday, reaching $106.46. The company had a trading volume of 260,241 shares, compared to its average volume of 947,653. The firm has a 50 day moving average of $114.52 and a 200 day moving average of $116.91. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 12 month low of $97.32 and a 12 month high of $129.50. The company has a market capitalization of $12.79 billion, a PE ratio of 48.17, a price-to-earnings-growth ratio of 3.82 and a beta of 1.06.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the previous year, the company earned $1.25 EPS. On average, equities analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. Revvity's payout ratio is currently 12.67%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on RVTY. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective for the company. in a research note on Friday, January 10th. Barclays raised their price target on Revvity from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Raymond James reiterated an "outperform" rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Bank of America raised shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 target price on the stock in a research note on Friday, December 13th. Finally, KeyCorp lifted their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $136.25.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.